Status: Recruiting
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders.
Participants needed: 10
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: William ShomaliUpdated: Dec 23, 2025Locations: 4
Eligibility criteria
Has as at least 2 readings with an absolute eosinophil count >= 1,500/mm^3 in th... [+19]
Active life-threatening complication(s) from underlying eosinophilic disease (i.... [+21]